News

Model-turned-activist Geena Rocero is stepping behind the camera, making her directorial debut with the upcoming short film ...
After turning down several new drugs and restricting use of another, Dr. Vinay Prasad drew the ire of the right-wing ...
Annabelle doll is back in the spotlight following Dan Rivera's death. A lookback at chilling tales of accidents and paranormal events linked to her.
Sarepta's gene therapy pipeline faces renewed scrutiny after a third patient death and FDA plans for a black box warning on Elevidys.
The estates for late actor Gene Hackman and his wife, Betsy, are being hit with creditors' claims over the duo's alleged debt, Us Weekly can exclusively report ...
Mattel unveils first Barbie doll with type 1 diabetes: 'We knew the time was right' Barbie with type 1 diabetes joins the toy manufacturer's ever-growing Fashionista line.
Mattel announced the release of the first-ever Barbie doll with type 1 diabetes, complete with a continuous glucose monitor and an insulin pump in Barbie's signature pink.
Barbie's first doll with Type 1 diabetes, which is available now for $10.99 each, includes a glucose monitor and insulin pump.
This is the first time such results have been achieved in both children and adult patients born with a specific type of congenital deafness.
Sangamo's investigational gene therapy has been tied to an improvement in kidney health deterioration at 52 weeks for patients with Fabry disease.
Nicole Verdun, top gene therapy regulator at the FDA, has been forced out of the agency.
Following a second patient death, Sarepta is temporarily suspending use of Elevidys in non-ambulatory DMD patients, pending evaluation of an enhanced immunosuppression regimen.